The global hard gelatin capsules market is set to experience substantial expansion, with sales anticipated to rise from USD 1,940.3 million in 2024 to an impressive USD 3,409.7 million by 2034. This significant growth trajectory represents a compound annual growth rate (CAGR) of 5.8% over the forecast period.

The increasing adoption of hard gelatin capsules in pharmaceuticals, nutraceuticals, and dietary supplements is fueling market demand. These capsules are widely preferred for their efficient drug delivery, bioavailability, and ease of consumption, making them a staple in the pharmaceutical industry. Additionally, advancements in capsule manufacturing technology and the rising trend toward customized drug formulations are further propelling market expansion.

The growth of the market is also driven by the increasing prevalence of chronic diseases, leading to heightened pharmaceutical production. Moreover, the rising consumer preference for gelatin-based supplements due to their superior digestibility and stability is contributing to market acceleration.

As industry players focus on product innovations, sustainable capsule production, and expanding applications, the global hard gelatin capsules market is expected to maintain its upward momentum, presenting lucrative opportunities for manufacturers and investors.

The hard gelatin capsules market is highly fragmented, with numerous companies actively developing innovative products to meet evolving customer demands.

Leading manufacturers are focusing on global expansion to increase revenue and strengthen their market presence. Many of these companies collaborate with research institutions to enhance product innovation and technological advancements.

Key strategies employed by manufacturers include agreements, product launches, research sponsorships, and strategic partnerships to drive sales and solidify their competitive position.

In terms of source, the industry is divided into type-A (pork skin), type-B gelatine (animal bones & calf skin), and fish bone gelatine

In terms of size, the industry is segregated into size “00” capsules, size “0” capsules, size “1” capsules, size “2” capsules, size “3” capsules, size “4” capsules, and size “5” capsules

In terms of route of administration, the industry is divided into oral administration and inhalation.

By End User:

In terms of end user, the industry is segregated into pharmaceutical companies, cosmetic & nutraceutical companies, and CROs & CDMOs

By Region:

Key countries of North America, Latin America, Europe, East Asia, South Asia & Pacific, Middle East and Africa (MEA) have been covered in the report.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: [email protected]
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube